Update on anti-N-methyl-D-aspartate receptor encephalitis in children and adolescents
- 1 December 2010
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Pediatrics
- Vol. 22 (6), 739-744
- https://doi.org/10.1097/mop.0b013e3283402d2f
Abstract
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a recently identified disorder that is increasingly recognized in children and adolescents. Prompt diagnosis and treatment are important to obtain full recovery. We review here the main clinical features and differential diagnosis and provide algorithms of the clinical correlates of antibody-mediated decrease of NMDAR and a suggested treatment approach. The sharp increase of patients identified with anti-NMDAR encephalitis reveals a multistage disorder that usually presents with psychiatric manifestations progressing to a decrease of verbal output, catatonia, seizures, dyskinesias, and frequent autonomic instability and hypoventilation. In adults, the disorder often occurs in association with a tumor that expresses NMDAR (usually ovarian teratoma), but in male patients and children the presence of a tumor is rare. Given that patients' antibodies have pathogenic effects on the NMDAR, immunotherapy and tumor resection, when appropriate, are often effective. The outcome is usually good, but the recovery is slow with frequent protracted symptoms of frontal lobe dysfunction. Anti-NMDAR encephalitis is a severe but treatable disorder that frequently affects children and adolescents and is likely under-recognized. The syndrome is highly predictable, recognizable on clinical grounds and can be confirmed with the demonstration of NMDAR antibodies.Keywords
This publication has 25 references indexed in Scilit:
- Opsoclonus-Myoclonus Syndrome in Anti-N-Methyl-D-Aspartate Receptor EncephalitisArchives of Neurology, 2010
- Complex partial status epilepticus revealing anti-NMDA receptor encephalitisEpileptic Disorders, 2009
- Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2009
- N‐methyl‐D‐aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargicaAnnals of Neurology, 2009
- Anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis in children and adolescentsAnnals of Neurology, 2009
- Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesThe Lancet Neurology, 2008
- The distinctive movement disorder of ovarian teratoma‐associated encephalitisMovement Disorders, 2008
- A patient with encephalitis associated with NMDA receptor antibodiesNature Clinical Practice Neurology, 2007
- Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratomaAnnals of Neurology, 2007
- Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratomaAnnals of Neurology, 2005